Buscar
Mostrando ítems 1-10 de 2056
Treatment of multiple sclerosis with interferons Tratamiento de la esclerosis multiple con interferones
(1996)
Despite the important achievements in clinical and experimental aspects of demylinatlng diseases and multiple sclerosis (MS), its pathogenesis still remains unknown. The most commonly held view is that it is an autoimmune ...
Análise dos parâmetros clínicos periodontais e expressão genética de interferons alfa, gama e genes relacionados em indivíduos portadores de Síndrome de Down com doença periodontal
(Universidade Estadual Paulista (Unesp), 2010-03-12)
A doença periodontal (DP) em indivíduos com Síndrome de Down (SD) se desenvolve com alta prevalência, precocemente, de modo rápido e generalizado em comparação com indivíduos não-sindrômicos. Foi demonstrado que portadores ...
Effect of Interferon-a on Experimental Septal Fibrosis of the Liver - Study with a New Model
(Brasil, 2001)
Interferon-a is used in antiviral therapy in humans, mainly for viral hepatitis B and C. An anti-fibrotic effect of interferon has been postulated even in the absence of anti-viral response, which suggests that interferon ...
Análise dos parâmetros clínicos periodontais e expressão genética de interferons alfa, gama e genes relacionados em indivíduos portadores de Síndrome de Down com doença periodontal
(Universidade Estadual Paulista (UNESP), 2014)
Interferon in Breast Cancer
(SAGE Publications, 1977-03-01)
The interferon production ability by leukocytes in vitro from 37 patients with mammary cancer was studied. The leukocytes were derived from patients between 27 and 80 years of age, 6 months and up to 28 years after removal ...
Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses
(American Association for the Advancement of Science, 2016)
Placenta damage caused by Zika virus infection impairs interferon lambda responses
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
(Brazilian Society of Infectious Diseases, 2008)
Chronic hepatitis C is often a progressive, fibrotic disease that can lead to cirrhosis and other complications. The recommended therapy is a combination of interferon and ribavirin. Besides its antiviral action, interferon ...